AG真人官方

UiPath, Inc. (PATH) 鈥� Form 4 filing dated 06/30/2025: Director Michael Lawrence Gordon reported the grant of 16,064 Restricted Stock Units (RSUs) on 06/26/2025 under the company鈥檚 non-employee director compensation plan. Each RSU converts into one Class A common share upon settlement and vests on the earlier of the 2026 annual meeting date or the first anniversary of the grant, contingent on continued board service. The transaction is coded 鈥淎,鈥� indicating an acquisition, and carries a stated price of $0.00 because it is a compensatory award rather than an open-market purchase. Following the grant, Gordon鈥檚 direct beneficial ownership rises to 175,464 Class A shares. No derivative securities were involved, and no sales were reported. Because the award is routine board compensation, market impact is expected to be limited, although insider acquisitions鈥攅ven compensatory鈥攃an be viewed modestly positively by some investors.

BioVie Inc. (BIVI) received Amendment No. 11 to Schedule 13D from long-time insiders Acuitas Group Holdings, LLC and its principal, Terren S. Peizer. The filing reconfirms their combined ownership of roughly 3.0 million Class A common shares, equal to 15.8 % of outstanding stock, after adjusting for the 1-for-10 reverse split completed on 6 August 2024. The ownership is split as follows: Acuitas鈥�3,043,574 shares (shared voting/dispositive power); Peizer鈥�3,050,394 shares (sole voting/dispositive power including 6,500 option shares and Acuitas鈥� warrant).

Governance development: Item 2 discloses that Mr. Peizer was sentenced on 23 June 2025 to 42 months in prison plus three years鈥� supervised release; he filed an appeal on 25 June 2025. This marks the first 13D acknowledging the criminal judgment, heightening key-person and reputational risk for BioVie.

Capital structure notes: Percentages are based on 18.57 million shares outstanding as of 2 June 2025 plus warrant dilution. The filing explicitly does not reflect the additional 1-for-10 reverse split scheduled for 7 July 2025, implying future mechanical changes to share counts but no change in economic ownership.

No recent trading: The reporting persons state they executed no transactions in the past 60 days.

Overall, the amendment chiefly updates (i) share counts post-split, (ii) confirms unchanged 15.8 % beneficial stake, and (iii) discloses Peizer鈥檚 criminal sentence鈥攊nformation that may influence investor perception of control, governance, and future strategic flexibility.

UiPath (PATH) Form 4 filing: Director Philippe Botteri received an annual grant of 16,064 Restricted Stock Units (RSUs) on 26 Jun 2025 under the company鈥檚 non-employee director compensation policy. Each RSU converts into one Class A share when vested. The award vests on the earlier of the next annual meeting or the first anniversary of the grant date, provided the director remains in service.

The RSUs were issued at a price of $0.00, so no cash changed hands and no open-market transaction occurred. Following the grant, Botteri鈥檚 beneficial ownership rises to 3,160,889 Class A shares. No derivative securities or additional transactions were reported. The filing contains no other material corporate developments or financial metrics and is considered routine, with negligible dilution relative to UiPath鈥檚 total share count.

UiPath, Inc. (PATH) 鈥� Form 4 filing dated 06/30/2025

CEO, Chairman and 10% owner Daniel Dines reported an open-market sale of 45,000 Class A shares at a weighted-average price of $12.7821 per share. The disposition was executed under a pre-arranged Rule 10b5-1 trading plan adopted earlier, as disclosed in Footnote 1. The price range for the transactions was $12.71-$12.85; detailed breakdowns are available upon request.

Post-transaction ownership:

• Indirect (Ice Vulcan Holding Ltd.): 5,553,376 Class A shares
• Direct: 24,918,585 Class A shares
• Indirect (spouse): 240,000 Class A shares

After the sale, Mr. Dines retains beneficial ownership of roughly 30.7 million shares, indicating he continues to hold a substantial equity stake. No derivative security transactions were reported.

The filing is routine in nature, reflects a relatively small (<1%) reduction of the insider鈥檚 total position, and does not alter the company鈥檚 capital structure.

BBVA (NYSE: BBVA) has cleared a pivotal regulatory hurdle in its planned acquisition of Banco de Sabadell. The Spanish Council of Ministers, in its session of 24 June 2025, approved the economic concentration arising from BBVA鈥檚 voluntary tender offer for 100% of Sabadell鈥檚 share capital. This authorization follows the Spanish competition authority鈥檚 approval on 30 April 2025 and is granted with an additional, undisclosed condition beyond the commitments BBVA had already presented.

Under Article 26.1(c) of Royal Decree 1066/2007, BBVA could have withdrawn the offer because the clearance is conditional. After reviewing the Council鈥檚 resolution, BBVA decided to keep the offer in force, signalling management鈥檚 confidence in meeting the new requirement and completing the transaction.

• Form type: 6-K (foreign issuer current report)
• Transaction: Voluntary tender offer for Banco de Sabadell, originally announced 9 May 2024
• Key date: Council approval issued 24 June 2025; BBVA confirmation dated 30 June 2025
• Regulatory status: Spanish merger-control process now concluded

The filing contains no financial figures or earnings updates, focusing solely on the regulatory progress of the proposed acquisition.

UiPath (NYSE:PATH) CEO, Chairman and 10% owner Daniel Dines filed a routine Form 4 reporting the sale of 45,000 Class A shares on 06/27/2025 at an average price of $12.78 under a Rule 10b5-1 trading plan, for proceeds of roughly $0.58 million.

Dines still beneficially owns about 30.8 million shares: 24.9 million directly, 5.6 million through Ice Vulcan Holding Ltd., and 240,000 held by his spouse. The sale represents less than 0.2% of his holdings and does not affect his control position. No derivative securities were involved, and no other material changes were disclosed.

UiPath (NYSE:PATH) filed a Form 4 disclosing that CEO, Chairman and 10% owner Daniel Dines sold 45,000 Class A shares on 26 Jun 2025 at an average price of $12.38, generating about $0.56 million. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

After the sale, Dines still beneficially owns roughly 30.8 million shares (direct, indirect and spouse holdings), so the disposal represents well under 1% of his position. No other transactions or derivative movements were reported.

UiPath (NYSE:PATH) filed a Form 4 showing CEO-Chairman Daniel Dines sold 45,000 Class A shares on 25 Jun 2025 at an average $12.55 under a Rule 10b5-1 plan. Post-sale, he still controls roughly 30.8 million shares, so the transaction equals <0.2% of his holdings and 鈮�$0.56 million in value鈥攂elow materiality thresholds.

UiPath CEO and Chairman Daniel Dines reported a significant insider transaction on June 24, 2025, selling 45,000 shares of Class A Common Stock at an average price of $12.4876 per share (ranging from $12.4150 to $12.5500). The transaction was executed through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains substantial holdings in UiPath:

• 24,918,585 shares held directly
• 5,733,376 shares held indirectly through Ice Vulcan Holding Limited
• 240,000 shares held indirectly through spouse

As a Director, CEO, Chairman, and 10% Owner, Dines maintains significant control over the company. The shares held through Ice Vulcan Holding Limited are controlled by Dines through a corporate structure where he retains sole voting and investment power.